Crestor is a statin and at its peak generated annual revenues of more than $7 billion but it lost patent protection in the US four years ago and sales have tumbled.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Astrazeneca (AZN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the ...

CARLSBAD, Calif. - Tyra Biosciences , Inc. (NASDAQ:TYRA), a biotech firm specializing in precision medicines targeting Fibroblast Growth Factor Receptor (FGFR) biology, today announced the appointment ...

Both types are effective at managing cholesterol, but researchers have uncovered some surprising side effects. Weight Gain: ...

We have yet to find the cure for cancer, but there are ways to treat the disease and mitigate your risk of dying from it - like these popular medications.

加利福尼亚州卡尔斯巴德 - 专注于靶向成纤维细胞生长因子受体（FGFR）生物学的精准医疗生物技术公司Tyra Biosciences, Inc. (NASDAQ: TYRA )今日宣布任命Adele Gulfo加入其董事会。根据 InvestingPro ...

Flagship Harbor Advisors LLC lowered its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 2.5% during the 4th ...